Haemagglutinin-strain B (Victoria-like)

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Afluria Tetra, FluLaval Tetra, Fluzone High-Dose Quadrivalent, Fluzone Quadrivalent, Influvac Tetra
Generic Name
Haemagglutinin-strain B (Victoria-like)
DrugBank Accession Number
DB15473
Background

Not Available

Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Inactivated
Synonyms
  • Haemagglutinin-strain B (Victoria)

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Afluria TetraHaemagglutinin-strain B (Victoria-like) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Yamagata-like) (15 mcg / 0.5 mL)SuspensionIntramuscularSeqirus Pty Ltd2020-09-23Not applicableCanada flag
Afluria TetraHaemagglutinin-strain B (Victoria-like) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Yamagata-like) (15 mcg / 0.5 mL)SuspensionIntramuscularSeqirus Pty Ltd2019-10-25Not applicableCanada flag
Afluria Tetra Injektionssuspension in einer FertigspritzeHaemagglutinin-strain B (Victoria-like) (15 mcg) + Haemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain A(H3N2) (15 mcg) + Influenza B virus B/Phuket/3073/2013 BVR-1B antigen (formaldehyde inactivated) (15 mcg)Injection, suspensionIntramuscularSeqirus Netherlands B.V.2020-05-26Not applicableAustria flag
Flucelvax QuadHaemagglutinin-strain B (Victoria-like) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Yamagata-like) (15 mcg / 0.5 mL)SuspensionIntramuscularSeqirus Uk LimitedNot applicableNot applicableCanada flag
Flucelvax QuadHaemagglutinin-strain B (Victoria-like) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Yamagata-like) (15 mcg / 0.5 mL)SuspensionIntramuscularSeqirus Uk Limited2020-09-21Not applicableCanada flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available

References

General References
Not Available
Not Available

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
4CompletedOtherHealthy Volunteers (HV) / Influenza immunization2somestatusstop reasonjust information to hide
3WithdrawnPreventionCoronavirus Disease 2019 (COVID‑19)1somestatusstop reasonjust information to hide
1CompletedPreventionCoronavirus Disease 2019 (COVID‑19) / Influenza, Human1somestatusstop reasonjust information to hide
1, 2CompletedPreventionInfluenza immunization3somestatusstop reasonjust information to hide
1, 2RecruitingPreventionInfluenza immunization1somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, suspensionIntramuscular
SuspensionIntramuscular
SuspensionIntramuscular; Subcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at August 30, 2019 15:25 / Updated at December 01, 2022 11:29